content

BMS obtains FDA approval for Opdivo as bladder cancer treatment

The US FDA has approved Bristol Myers Squibbโ€™s (BMS) Opdivo (nivolumab) as an adjuvant therapy for urothelial carcinoma (UC) patients at increased risk of...

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY Receives Full U.S. FDA Approval for Individuals 16 Years and Older

Pfizer Inc. and BioNTech SE announced that the U.S. FDA approved the Biologics License Application (BLA) for COMIRNATYยฎ (COVID-19 Vaccine, mRNA) to prevent COVID-19...

McMaster, Sartorius Enter Biomanufacturing Partnership

Sartorius Stedim Biotech, an international partner of the biopharmaceutical industry, has entered into a partnership with McMaster University to improve manufacturing processes of antibody...

AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new facility at its Copenhagen, Denmark site....

Clinerion patent for technology underpinning Patient Network Explorer is published

The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as...

Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world

Zydus Cadila announced that the company has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the...

Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United States

Zydus Pharmaceuticals Inc, USA (a 100% subsidiary of Cadila Healthcare Limited (Zydus Cadila), a leading innovation-driven, global healthcare provider, has signed a license and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read